Kazuki Takada
- Oncology top 1%
- Rheumatology top 0.5%
- Pulmonary and Respiratory Medicine top 2%
- Immunology top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Co-authors
- Yoshihiko MaeharaTatsuro OkamotoShinkichi TakamoriGouji ToyokawaGabor G. IlleiFumihiro ShojiTakaki AkamineYoshinao Oda
- Topics
- Cancer Immunotherapy and Biomarkers (51 papers)Lung Cancer Treatments and Mutations (38 papers)Lung Cancer Research Studies (26 papers)
- Cited by
- RheumatologyOncologyImmunology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Kazuki Takada
136 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 120
- Oncology 1.8k
- Rheumatology 1.3k
- Pulmonary and Respiratory Medicine 1.2k
- Immunology 1.1k
- Radiology, Nuclear Medicine and Imaging 601
Countries citing papers authored by Kazuki Takada
This map shows the geographic impact of Kazuki Takada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuki Takada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuki Takada more than expected).
Fields of papers citing papers by Kazuki Takada
This network shows the impact of papers produced by Kazuki Takada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuki Takada. The network helps show where Kazuki Takada may publish in the future.
Co-authorship network of co-authors of Kazuki Takada
This figure shows the co-authorship network connecting the top 25 collaborators of Kazuki Takada. A scholar is included among the top collaborators of Kazuki Takada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuki Takada. Kazuki Takada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 13 | |
| 7 | 0 | |
| 8 | 4 | |
| 9 | 11 | |
| 10 | 9 | |
| 11 | 29 | |
| 12 | 12 | |
| 13 | 9 | |
| 14 | 51 | |
| 15 | 38 | |
| 16 | 1 | |
| 17 | 44 | |
| 18 | 1 | |
| 19 | 4 | |
| 20 | 11 |
About Kazuki Takada
Kazuki Takada is a scholar working on Oncology, Biological Psychiatry and Pulmonary and Respiratory Medicine, having authored 149 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (51 papers), Lung Cancer Treatments and Mutations (38 papers) and Lung Cancer Research Studies (26 papers). The work is most often cited by research in Rheumatology (1.3k citations), Oncology (1.8k citations) and Immunology (1.1k citations). Kazuki Takada has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yoshihiko Maehara, Tatsuro Okamoto, Shinkichi Takamori, Gouji Toyokawa, Gabor G. Illei, Fumihiro Shoji, Takaki Akamine, Yoshinao Oda, Nobuyuki Miyasaka and Cheryl Yarboro. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.